Revive Therapeutics Ltd. (CSE:RVV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
+0.0050 (33.33%)
Apr 2, 2025, 11:38 AM EST

Revive Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
641614818755
Upgrade
Market Cap Growth
-61.08%-73.99%-89.09%-21.23%240.94%698.49%
Upgrade
Enterprise Value
631414316955
Upgrade
Last Close Price
0.010.010.040.460.590.29
Upgrade
PB Ratio
0.980.581.5111.716.507.39
Upgrade
P/TBV Ratio
---1436.1111.4828.48
Upgrade
Debt / Equity Ratio
-0.000.020.030.010.06
Upgrade
Quick Ratio
0.020.240.650.9927.994.46
Upgrade
Current Ratio
0.060.340.691.0028.115.80
Upgrade
Return on Equity (ROE)
-66.49%-62.83%-54.36%-86.00%-111.04%-128.29%
Upgrade
Return on Assets (ROA)
-16.18%-16.52%-22.05%-47.58%-60.99%-48.28%
Upgrade
Return on Capital (ROIC)
-22.73%-22.68%-29.02%-52.90%-62.55%-52.02%
Upgrade
Earnings Yield
-84.33%-134.24%-39.27%-12.07%-10.74%-9.80%
Upgrade
FCF Yield
-62.11%-78.62%-37.44%-8.85%-4.44%-4.58%
Upgrade
Buyback Yield / Dilution
-15.37%-12.11%-6.13%-19.54%-150.28%-67.08%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.